Medications

Q&A: Experts discuss pros, cons of new Alzheimer's drug

Patient care teams are preparing to offer lecanemab, a new Alzheimer's disease treatment expected to soon receive approval from the U.S. Food and Drug Administration (FDA), to patients in the coming months.

Oncology & Cancer

Blood test aids in predicting lung cancer mortality risk

A blood-based test developed by researchers at The University of Texas MD Anderson Cancer Center can efficiently predict an individual's risk of dying from lung cancer when combined with a personalized risk model.

Health

Study shines light on 'low-value' vitamin D tests

Doctors are ordering unnecessary, costly and invasive blood tests for children to detect vitamin D deficiency, when instead it would be better to take simple preventative steps to ensure children receive supplements of the ...

page 16 from 40